Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.
about
Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5Association of extracellular matrix proteins fibulin-1 and fibulin-2 with fibronectin in bone marrow stromaAssociation of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cellsCRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cellsEffect of the interaction between fibronectin and VLA-4 on the proliferation of human B cells, especially a novel human B-cell line, OPM-3Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading.Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinLymphopoiesis and matrix glycoprotein SC1/ECM2.Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell lineTranscriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration.The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1.Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules.α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK).Identification of stromal cell products that interact with pre-B cellsVLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.Engineering microenvironments for embryonic stem cell differentiation to cardiomyocytes.Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy.Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5.Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.Signal transduction, mitotic catastrophes, and death in T-cell development.Protein kinase C-beta, fibronectin, alpha(5)beta(1)-integrin, and tumor necrosis factor-alpha are required for phorbol diester-induced apoptosis in human myeloid leukemia cells.Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma.Isolation of Ich-1S (caspase-2S)-binding protein that partially inhibits caspase activity.Enhancement of activation-induced cell death by fibronectin in murine CD4+ CD8+ thymocytes.The role of extracellular matrix stiffness in megakaryocyte and platelet development and function.The influence of extracellular matrix proteins and mesenchymal stem cells on erythropoietic cell maturation.Differential induction of apoptosis in B16 melanoma and EL-4 lymphoma cells by cytostatin and bactobolin.
P2860
Q24308850-30EDAB24-8468-45D8-B835-697CC6139751Q28137958-D77EFAF5-6B67-4CC0-9B4F-7ECC7EA2072AQ28264351-412CC168-92D6-47C6-9093-19CE1D6851F3Q28284723-2DB13D98-9470-4B0C-B2DB-4EB45CBCA870Q28647333-9E63F2F1-9DBF-4D73-A98D-4CC8EC67F195Q30176186-B034F916-7F62-40DB-8260-9DC0145E5ECCQ33511345-DBD8A970-5EA1-4AEC-8FC5-B7E886CB5F23Q33536274-C2B27DD1-B542-4A63-8EE5-309FE640533BQ33775054-D583819E-C01E-4608-80FF-467B2CE95DE4Q33854194-42631017-ACF4-4BE1-A291-6DD83C32AE95Q33857180-A89BDF0B-8B54-48B8-AEF3-5165C5C45B5EQ34434204-137929B2-C396-49BF-AF79-E57DB0DB706EQ35733270-D1FED5FF-59EF-4D67-8071-F72A1F74EFFAQ36006896-5073A845-2E6B-47D9-851A-86A6770B0301Q36237195-7DE28602-DB39-461E-9504-55CFC84624B6Q37385089-DE05FAA8-1F1F-4A63-917A-BA48E8EB489FQ37598911-3FE52556-0013-443E-A8A2-FEBB29F9931FQ37973062-95B6A609-B8F4-4F95-8B94-A89A5D0A8873Q38343521-F836E943-A5F0-4448-A3CA-A8311FCE4977Q39761913-5849FEFA-F3A0-4B1C-8E23-BADA3AEE5C60Q39939244-BD8A65A1-2216-4C56-9417-B8B939C8FF9CQ40022229-0E6205EB-E9D0-4067-826C-73D53CFF2EFDQ40059658-DB9E1ADA-A3A5-4B66-A341-4756B920FC02Q40495457-0DCEDB0C-47EB-4AD0-B7DC-BA728A526DE2Q40762833-388041AB-9F0B-459F-A4CC-4040FA054741Q41032940-D02CE211-9E10-423E-9495-74A134BA09D8Q42803764-CAB0FED9-96A4-4A61-BF9B-0B59CEF3ACA4Q42819942-070795DF-0AAB-431F-B155-B657C01AF7DEQ48106053-D4E4A460-6958-4171-A891-00F4D16908E1Q50550999-21FEE053-4993-4F50-89F4-E8090AA62C82Q51091029-E5EB265C-7C9E-4F42-99C7-213D54DBDAB1
P2860
Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Induction of programmed cell d ...... tion with very late antigen 5.
@en
type
label
Induction of programmed cell d ...... tion with very late antigen 5.
@en
prefLabel
Induction of programmed cell d ...... tion with very late antigen 5.
@en
P2093
P2860
P356
P1476
Induction of programmed cell d ...... tion with very late antigen 5.
@en
P2093
Hashimoto K
Ishihara K
Ishikawa J
Kanakura Y
Kanayama Y
Kitayama H
Sugahara H
P2860
P304
P356
10.1084/JEM.179.6.1757
P407
P577
1994-06-01T00:00:00Z